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Improving long-term outcome of depression  
in primary care:   
a review of randomized controlled trials  
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Abstract   
 
Background and objective: Depression is often a recurrent or persistent disorder, 
associated with high levels of disability. Since the majority of depressed patients are treated 
in primary care, it is clear that to attain more favorable long-term outcomes more effective 
treatments in this setting are needed.  The goal of this study was to review the strategies 
used for improvement of routine treatment in terms of their effects on patient outcome.  
 
Methods: We conducted a systematic literature search to identify improvement strategies. 
Randomized controlled trials conducted in primary care, reporting at least six months effects 
on depression course and outcome of psychological treatments and supportive interventions 
for major depression in adults were included. The search strategy was expanded to include 
literature on patient outcome of educational programs and targeted approaches used in other 
settings. Results are presented in the form of a narrative review.  
 
Results : Four strategies were identified: (1) training primary care physicians (PCPs) – this 
appears ineffective; (2) supporting PCPs management of depressed patients by other 
professionals, which includes collaborative care models– this may result in better short term 
outcomes but does not prevent recurrence ; (3)  quality improvement, by adressing both the 
contents of treatment as well as the broader care context in which treatment is delivered- this 
shows improved outcomes at 6 months, and there is some evidence of longer term 
effectiveness; and (4) integration of recurrence and chronicity prevention strategies into 
treatment from the start - these have not been shown to be effective.  
 
Conclusions: Findings show that effects of the reviewed strategies generally do not seem to 
persist over time. Moreover, with the exception of some US-based studies, no clear 
superiority over usual care has been demonstrated. We conclude that for improving long-





Depression is a common mental disorder, with a life time prevalence of up to 15% for men 
and around 24% for women in the general population (Bijl et al. 1998; Kessler et al. 2003). 
Increasingly, it has become clear that the concept of depression as a transient, acute and 
self-limiting disorder is incorrect. Longitudinal research has shown high rates of relapse, 
recurrence and chronicity (Judd, 1997; Mueller et al. 1999; Lin et al. 1999; Simon 2000; 
Solomon et al. 2000; Brink et al. 2001; Spijker et al. 2002). For many patients, depression is 
a recurrent and potentially persistent disorder, associated with levels of social and vocational 
disability comparable to rates found in chronic somatic illnesses (Ormel et al. 1994, 2004; 
Wells & Sherbourne 1999).  
Primary care physicians (PCPs) are the most important initial health care contact for 
nearly all patients with mental health or psychosocial problems and depression is no 
exception. Since the majority of depressed patients continue to be treated in primary care 
(Spijker et al. 2001) , this can be considered to be the de facto mental health care setting for 
depression (Regier et al. 1998). However, the appropriateness of this situation has been 
questioned. PCP’s have been found to under recognize and under treat a substantial number 
of depressive patients (Őstőn & Sartorius 1995 ; Tiemens et al. 1996; Hirschfeld et al. 1997; 
Schulberg et al. 1997; Goldberg et al. 1998; Os et al. 1999). Although more recent findings 
indicate that recognition of depression in general practice has improved, providing effective 
treatment remains an issue (Davidson & Meltzer-Brody 1999; Andrews et al. 2000). 
Moreover, especially from a long-term perspective, not all treatment is effective (Von Korff & 
Goldberg 2001).  
Evidence-based, standardized management guidelines for the treatment of 
depression in primary care have been available since the 1990’s (Paykel & Priest 1992; 
AHCPR 1993, Schulberg et al. 1998; Ellis & Smith 2002; Marwijk et al. 1994, 2003; NICE 
2004 ). Summarized, these recommend a combination of antidepressant medication and 
brief, supportive counselling and include criteria for patient referral to specialized mental 




recover or improve significantly within a few months. Howver, many do not recover, or only 
partially, while about a fifth of these patients has episodes lasting more than a year and the 
relapse rate is high, in particular in those patients who achieve only partial remission (Brilman 
et al. 1992; Ormel et al. 1993; Lin et al. 1998; Tiemens 1999; Simon 2000; Brink et al. 2002; 
Os et al. 2006). In sum, the need for more effective treatment of patients with major 
depression in primary care is clear. However, it is less evident how this improvement can be 
realized: which interventions or strategies should be used in order to attain better long-term 
patient outcomes in this setting ?   
In the present paper, we critically review a number of approaches that have been 
designed and tested to improve routine care for depression in primary care. The leading  
question is: is this method effective in improving long-term (beyond six months) depression 
outcomes in primary care patients? We explicitly searched the literature for clues as to which 
intervention succeeds in achieving recovery and in maintaining this over time, as shown by 
reduced rates of depression relapse, recurrence and persistence. We identified four 
approaches, which will be briefly introduced here.  
1: The first and historically oldest strategy focuses on education and training of PCPs 
( paragraph 3.1). This is based on the assumption that education will change PCP behavior, 
improve skills in patient care and thereby also enhance clinical outcomes.  
2: A second strategy explores ways in which PCPs can be supported in their 
diagnosis and management of depressed patients (par. 3.2). This includes brief 
psychological interventions by other primary care providers such as counsellors and 
collaborative care models where patient care is shared (through feedback and consultation) 
with mental health professionals such as psychiatrists and psychologists.  
3: The third and most recent strategy not only addresses the contents of depression 
care itself but also the broader care context in which this treatment is usually delivered (par.  
3.3). This has involved explorations of potentially more effective ways of organizing and 
delivering support to PCPs and includes studies in which nurses or case managers are 




and treatment adherence, and comprehensive quality improvement programs which not only 
include training packages for PCPs and other qualified staff members, but also offer regular 
patient follow-up monitoring contacts and improved access to specialist care, if necessary.  
4: Also of recent date is the fourth strategy, characterized by the integration of 
depression relapse- and recurrence prevention strategies into treatment from the start (par. 
3.4) . Given the high risks of depression becoming a recurrent or persistent disorder even 
despite recognition and treatment, further targeting of treatment to individual patients seems 
a rational way to improve long-term patient outcomes, but studies evaluating these 
interventions for patients considered to be prone to relapse and recurrence are still rare. The 
few studies that have been conducted will be looked at in more detail.  
In the final section of this paper (par. 3.5) we will look outside of the primary care 
setting to examine approaches used in outpatient and convenience patient samples and 
inspect these on their potential for improving long-term outcome of depression.  
 
2  Methods 
 
2.1 Search procedure 
We conducted a systematic literature search. First, we searched in major electronic 
bibliographical databases, i.e. Medline, Pubmed, PsycLIT, PsycINFO, Current Contents and 
the Cochrane Library, to identify studies on depression treatment in primary care settings. 
Central search terms were major depression / depressive episode; primary care treatment; 
and randomized controlled (clinical) trial. These were coupled separately with the following 
terms: course; outcome; chronicity (persistence) ; recurrence; relapse; remission; recovery; 
long-term management; psychotherapy; antidepressant medication; relapse prevention; 
intervention. Secondly, we collected the available professional Guidelines and major meta-
analyses and reviews published on the subject. By means of the 'snowball-effect' (i.e. using 
references in the published articles) we retrieved additional publications that were examined 




strategy to include literature on patient outcomes of PCP educational programs and of 
targeted approaches used in other care settings (outpatient, convenience samples) to 
improve long-term depression outcomes.  
 
2.2. Selection criteria  
We included studies if they were randomized controlled trials (RCTs) conducted in primary 
care and reporting at least six months patient outcome data of psychological treatments or 
supportive interventions for major depression (MD; DSM, APA 1994) or depressive episode 
(ICD-10; WHO 1992). Studies comparing effectiveness of psychotherapy and 
pharmacotherapy with care as usual (CAU) by the primary care physician were included, but 
not studies that examined effects of antidepressants (AD) only. Several good quality reviews 
and meta-analyses on this latter subject are available (e.g. Mulrow et al. 2000; Simon 2002; 
MacGillivray et al. 2003; Arroll et al. 2005). Furthermore, studies had to be conducted in the 
adult population (≥ 18 years) and we excluded studies limited to selected patient groups such 
as the elderly. Finally, publications had to be available in English.    
 
The quality of the trials was assessed as follows. Depression diagnosis had to have been 
established by a standardized measure, preferably a structured interview. In the absence of a 
research diagnosis, symptoms assessed by reliable and valid (self-report) questionnaires 
had to be reported. We required that all interventions, the study design, randomization 
procedure and treatment assignment, as well as patient recruitment and attrition were 
described adequately. Also, the main outcome analyses should have covered all patients 
initially included in the research, hence on an intention-to-treat basis.  
 
2.3 Presentation  
We present the results in the form of a narrative review, which we consider to be more 
informative on the interventions than a meta-analysis or a systematic review, and thus better 
suited for our purposes. All study reports were summarized with regard to size and 




measuring instruments, contents and format of the intervention, and the actual depression 
outcomes observed at the follow-up assessments, if available. This information will be 
presented in the next section (paragraphs 3.1 - 3.4) that includes three tables outlining the 
main study characteristics, format and contents of the interventions and key results on 
depression outcome.  
 
3. Improving long-term outcome of depression in primary care  
We identified four approaches.  
 
3.1 Training primary care physicians  
Historically, the oldest wave of efforts to improve depression outcomes in primary care 
focuses on education and training of PCPs. Developing and disseminating evidence-based, 
standardized management guidelines are essential in this approach. Several strategies to 
promote guideline concordant behaviour can be distinguished, ranging from simply 
distributing these guidelines to all registered practicing PCPs to comprehensive postgraduate 
training and implementation programs (Thompson et al. 2000; Baker et al. 2001). However, 
evidence for the underlying assumption that educating physicians will by definition improve 
depression outcomes of their patients has long remained inconclusive because many studies 
mainly addressed physician behavior and other process outcomes (Kroenke et al. 2000; 
Hodges et al. 2001; Gilbody et al. 2003). It is now clear that studies that have evaluated 
clinical effectiveness, generally show that these programs are well received but fail to 
achieve substantial or enduring improvements in depression outcomes (Lin et al. 1997; 
Tiemens et al. 1999; Worrall et al. 1999; Brown et al. 2000; Thompson et al. 2000; Os et al. 





3.2 Supporting the PCP : Enhanced treatment and collaborative care  
Key characteristic of the second strategy to improve treatment of depression in primary care 
is the involvement of other (mental health) professionals. Enhanced treatments include brief 
psychological interventions by other primary care providers such as social workers and 
counsellors, and collaborative care models, in which psychologists deliver (brief) 
psychotherapy, psychiatrists provide consultation on diagnosis and medication management, 
and nurses educate patients in problem-solving skills or monitor adherence to antidepressant 
medication. We identified eight studies about this approach that fitted our criteria: 1 on 
consultation liaison psychiatry, 4 studies on counselling and 3 studies on psychotherapy. 
These studies will be described in this section; main characteristics and findings are 
summarized in Table 1.  
 
 
Legend of abbreviations  
 
General:   
FU = follow-up; sx = symptoms 
 
Treatment:   
GP = general practioner; PCP= primary care physician; MD=Major Depression;  
PN = Practice Nurse; UC = usual care ; AD=antidepressant medication; COUN=Counselling; CBT= Cognitive 
Behavioral Therapy; CT = Cognitive therapy; CLP = Consultation Liaison Psychiatry ; CM= care management 
;DRP= Depression Recurrence prevention ;  
FB= feedback; FCM= Feedback & Care Management ;  GC =  generic counselling ; 
IPT= Interpersonal therapy; NDC = non-directive counselling; NTC = Nurse Telehealth Care ; PC= Psychiatric 
Consultation; PST= Problem Solving treatment ; SWC= Social Work Counselling; PDC = Psychodynamic 
counselling; QEC =Quest Enhanced Care;  
QI = Quality improvement ; QI-M= Quality improvement – focus on medication; QI-T= Quality improvement with 
focus on Therapy 
 
Outcome measures:  
BDI= Beck Depression Inventory; CES-D= Center for epidemiologic studies–Depression scale ; CIDI= Composite 
Diagnostic Interview Schedule; SCID= Structured Clinical Interview; CIS=Clinical Interview Schedule; HAD = 
Hospital Anxiety and Depression scale; HRSD=Hamilton Rating Scale for Depression; HAM-D = Hamilton 
depression scale ;  
IDS = Inventory of Depressive Symptomatology; PSE= Present State Examination; RDC=Research Diagnostic 

















Patient sample Depression outcome measures & 
criteria 
CONSULTATION  LIAISON  PSYCHIATRY  (CLP)    
 
Katon et al,   





1: CLP ;  n = 108 
 
2: UC ;    n = 109 
 
 




phase: 3 - 7 mths 
 
By PCP  
 




N = 217   
 




Diagnosis: MD according to IDS  
 
Improvement :  
≥ 50% change in IDS     
≥ 50% improvement in SCL-90 depression   
COUNSELLING       
 
Corney,  






1: Social Work Counselling (SWC);  
n = 41 
 
2: UC    ;  n = 39 
 
Max. 6 months;  
actual number not 
clear 
Identification by GP: women 
18-45 presenting with 
depression (symptoms either 
appeared or intensified in 
previous  3 months)  
 
Inclusion by psychiatrist : 
CIS depressive symptoms + 
clinical severity rating ≥ 2 
 
N = 80 
 




CIS Severity rating , range 1 – 5 
 
Improvement :  
Follow-up CIS severity rating ≤ 1 
   
 
Ward et  al, 2000;  
&    







1:Non-Directive Counseling (NDC)   
2: Cognitive Behavioural Therapy (CBT)   
3: UC 
 
Randomised between all  treatments:  
n= 197; NDC:  67, CBT: 63, UC: 67  
 
Randomised between 2 treatments:  
n = 130 ; NDC : 59, CBT: 71 
 
Preference: n = 137;  
NDC: 54, CBT: 81, UC: 2 
 
NDC: mean 6.4 
sessions 
 
CBT : mean 5 
sessions 
 




Identification by GP: 
diagnosis of depression or  
mixed depression/anxiety 
& psychological intervention 
indicated.  
 
BDI score  ≥ 14 
 
No current AD use 
No psychological therapy in 
past 6 months 
 
 
N =  464   
 
77 %  ♀, mean age : 37 
 
62 % MD  
( including 24% mixed anx / 
dep) 
 


















Patient sample Depression outcome measures & 
criteria 
 
Chilvers et al,  
2001 
 






1:  Generic Counselling (GC)  
- randomised: n = 52 
- preference:  n = 140 
 
2: AD by own GP 
- randomised: n = 51 




GC:  6 sessions  




Identification by GP 
(checklist) ;  
 




N = 323 
 
75  % ♀, mean age: 37 
 
GP rating of severity:   
mild: 24%  
moderate: 66%   
severe: 7 %   
 
 
Diagnosis: RDC criteria ; BDI; GP casenotes 
 
Time to remission;  
Remission : BDI < 10, RDC ≤ 4 or clear 
documentation in GP notes that patient was well; 
 
Relapse: deterioration within 6 m of remission 
 
Global outcome rating by psychiatrist using all 
data sources:  good = response to treatment 
within 8 wks& staying well; moderate = slow 
response to treatment but remained well or well 
initially but became unwell later; poor =remained 
depressed 
 
Simpson et al,  
2003   
 




1: Psychodynamic Counselling (PDC);  
n= 73; 
 
2: UC:    n=72 
 
PDC:   
6 -12 sessions  
 
mean: 5 sessions; 
88% at least 1 ;  
74% ≥ 4 
Initially referral by GP but 
changed to screening 
because of slow referral rates  
 
chronic depression: 
BDI ≥ 14   ; Duration ≥ 6 
months but < 5 years  
 
Exclusion of difficult or hard to 
treat patients (?) 
 
N = 145  
 
80  % ♀, mean age: 43 
 
Note: mean BDI higher in 





Chronic MD: BDI ≥ 14   
mild to moderate depression: BDI 14 - 23;  














Patient sample Depression outcome measures & 
criteria 
PSYCHOTHERAPY      
 





1: IPT  acute (16 sessions 1/ wk)   + 
continuation (4 sessions 1/mth) ; n = 93 
 
2: AD acute (bi- weekly visits during 16 
wks) + continuation (4 visists / 1 month) ;  
n =  91 
 





IPT: 51 %  
completed  
acute phase; of 
those , 83% 
completed contin.  
 
AD: 55 % acute 




3 phase assessment:  
screening; interview;  
final selection by psychiatrist 
 
MD &  HRSD > 12 
 
N = 276 
 
83 % ♀ , mean age:  38 
 
 
Diagnosis: DSM-III-r MD + HRSD 
 
Recovery: HRSD < 8 
 
Partial recovery: HRSD > 8 < 13 
 
No recovery: HRSD > 12 
 





1: brief Cognitive Therapy ; n =24 
 




CT mean number 
of sessions : 7  
 
 
Referral by GP;   
Eligibility determined by 
psychiatrist:  
MD &  BDI > 19 
 
 
N = 48 
 
67% ♀, mean age: 41 
 
mean duration: 8.6 months;  
60% recurrent  
 
Diagnosis: DSM-III-r  
 
Improvement : changes in BDI, HRSD 
 
Relapse: authors refer to NIMH criteria but 
provide no clear definition  
 
Katon et al, 1996 
&  






1: brief CBT ; n= 77 
 
2: UC ;  n = 76 
 
CBT: 6 wks, 4 - 6 
sessions 
 
FU monitoring : up 









N = 153 
74 % ♀, mean age: 47 
 
MD : 43 %  
 
 
SCL-90 depression scale:  ≥ 50% improvement 
 












last FU assessment  
+ attrition 
 
Results: Depression Outcome  
 
Conclusions  
CONSULTATION  LIAISON  PSYCHIATRY   (CLP)   
 
Katon et al, 
1995 &  







response ?   
 
7 months (MD patients only):  
Improved ≥ 50% on SCL depression scale:  
CLP : 75 % , UC: 44 % 
 
At 19 months : no differences in relapse rates and 
depressive symptoms 
 
At 7 months, more improvement in CLP patients 
 
At 19 months: no differences  






6 months  
 
100% , n = 80 
 
 
Improvement : SWC: 68 % , UC:  62 %   
 
Link with duration: 72% of SWC-patients whose sx had 
intensified benefited vs. 45 % of  SWC with new 
depression 
 
SWC no more effective than UC  overall ( improvement rate 65 %) ;  
 
SWC  more effective than UC for more chronic depression 
 
Ward et al  




response : 81 % ,  n =  
 
 
Faster resolution of depressive sx by both NDC & CBT 
at 4 months;  




NDC and CBT equally effective and superior to UC at 4 months  
 
Neither NDC nor CBT more effective than UC in symptom reduction over 12 months 
 
Treatment preference not related to clinical outcome 
 
 




response:  64 % ( n= 207) for 
questionnaires,  96 %  
( n=311) for GPcase note 
reviews   
 
 
Remission:  68 %  -  similar in each group  
 
Time to remission (median) : 3 months; for AD: 2 mths   
 
Relapse: 15 %     
 
Global outcome rating by psychiatrist:   
good : 33 %, moderate: 31 %, poor: 37 % 
 
GC and AD equally effective, time to remission slightly shorter with AD  
 
No remission in 32 % and of those remitted, 15% relapsed within 1 year 
 
No difference in psychiatrist’s overall outcome assessment between any of the groups 
  








last FU assessment  
+ attrition 
 








12 months   
 
80% , n  = 115 
 
 
Not  recovered ( still a case):   
all patients:  PDC:  48 % , UC : 64 %  
depression of mild-moderate severity: 32 % vs 57 %;  
depression of higher severity: 20 % in both PDC + UC 
 
Improvement in mean BDI scores:  
PDC:  6.7  (22 -> 15.3) ; UC: 4.7 (19.7 -> 15)  
  
More recovery with PDC   
 
No differences in improvement of depressive symptoms 
  
PSYCHOTHER  APY   
 




n = ?   
  
 
Recovery:        Partial recovery:     No recovery:         
IPT: 46 %           35 %                     19  % 
AD: 48 %            27 %                     25  %  
UC: 18 %            34 %                     48  % 
 
IPT and AD more effective than usual care  
 
No significant outcome differences at any time point between IPT and AD  
 




58 weeks  
 
50%  
CT:  n = 16 ( 33% drop out ) 
UC: n =   8 ( 66 % drop out ) 
 
Recovered at 7 wks : CT: 63 %, UC:  34 %   
 
Relapse:  CT: 7 % , UC: 50 %   
 
Mean HRSD score at w 58 lower in CT patients  
 
CT patients recovered earlier  
 
trend towards fewer relapses and greater symptom reduction over FU with CT 
 
But: small numbers and high , differential dropout 
 
 
Katon et al, 
1996 &  
Lin et al, 1998, 
1999 
 
19 months  
 
n = ?  
 
( 7 months: 77 % ,  n = 117)    
 
At 4 months (  MD patients only) :  
MD diagnosis :  CBT: 7  % , UC : 23 % 
 
At 7 months: Improved ≥ 50% SCL depression scale:  
CBT: 70 %, UC: 42 %   
 
19 months : similar relapse rates and symptoms  
 
7 months: greater improvement with CBT  
 





Consultation Liaison Psychiatry (CLP)  
We found one study examining the potential value of CLP for depression treatment in primary 
care. Katon and coworkers (1995 ) report results of a collaborative care RCT which included 
a comparison of co-management by a psychiatrist and a PCP, with depressed patients 
alternating visits in combination with psycho education and AD monitoring by the psychiatrist 
with usual care. PCPs in the CLP–arm were also offered education and case by case 
consultation. Forty-two percent of included patients were classified as having MD. Seven 
months later, CLP-patients with MD showed greater improvement in depressive symptoms 
overall than those randomized to usual care. No data is provided on recovery or persistence 
of MD.  
 
Counselling  
Four counselling studies fitted our inclusion criteria; two of them incorporated patient 
preference arms in the design. All four were from the United Kingdom (UK), reflecting the fact 
that counselling has become commonplace in primary care in this country. General 
practioners use the assistance of counsellors for a range of psychosocial and psychological 
problems, including depression (Churchill et al. 1999; Bower et al. 2000, 2002). Counsellors 
come from diverse professional backgrounds and use a variety of models and techniques. 
Next to the key element of ”reflective listening to enable the patient to resolve their own 
difficulties“ (from the formal counselling definition used for the Cochrane review by Bower 
and coworkers, 2002: p.5), counselling as developed within the context of the UK healthcare 
system may also include the use of psychotherapeutic techniques, more directive advise and 
the provision of practical help to address the patients’ problems.  
 The social work counselling (SWC) in the trial by Corney (1981, 1984, 1987) was 
provided by social workers already attached to the health centers involved. No specific 
guidelines were given. Counsellors were instructed to see their clients on a regular basis and 




SWC was found no more effective than usual care (UC), but women with more chronic 
depression benefited more from the input of SWC than from UC, while for women with a 
more recent onset of depression the reverse was true. Thus, there were indications that 
differential outcome was linked to the chronicity of the patient’s depression.   
 Ward and co-workers (2000; King et al. 2000) compared effectiveness of non-
directive counselling (NDC) relative to effects of cognitive behavioral therapy (CBT) or usual 
care. Eligible patients who refused random assignment were given a choice between the 
treatments; most preferred CBT. After 12 months, no meaningful differences in outcome 
were found between the treatment groups.  
 Chilvers and associates (2001) compared generic counselling (GC) with 
antidepressants (AD). Again, there was no specific treatment protocol: counsellors could use 
whichever approach they believed was most suitable for their patients, given the diagnosis of 
depression. In this trial only one third of the participants agreed to the randomized treatment 
assignment; the majority of those in the preference arm chose counselling over AD. Main 
results were that after one year there were no significant differences between treatment 
groups and also that receiving the treatment of preference was not related to depression 
outcome.  
 Finally, the trial by Simpson and co-workers (2000, 2003) evaluated effectiveness of 
psychodynamic counselling (PDC) and usual care for patients with chronic depression. As far 
as we can establish, the PDC was not specifically provided to address the persistent nature 
of depression. Rather, these patients were chosen because of the constant workload they 
present for GPs, in terms of time spent in consultation and as high consumers of 
psychotropic drugs. After one year, more PDC than UC patients had recovered. Thus, this is 
the only study that showed counselling to be more effective than usual care.  
 
Psychotherapy 
Four studies fitted our inclusion criteria, among them the study by Ward and colleagues that 




carried out in the UK and two in the United States of America (USA). Therapies that were 
tested are: interpersonal therapy (IPT; 1 study), cognitive therapy (CT) and cognitive 
behavioral therapy (CBT; 2 studies).  
 
IPT was developed by Klerman and colleagues (1984) as a therapy for improvement of 
interpersonal skills and coping. The purpose of IPT for depression is to alleviate symptoms 
and improve interpersonal functioning by clarifying the problem areas associated with onset 
of depression, followed by refocusing and choosing alternative, more effective strategies for 
dealing with these stressors (Weissman & Markowitz, 1994).  
 The RCT carried out in the USA by Schulberg and coworkers (1996, 1998) compared 
effectiveness of IPT for depression treatment in primary care with antidepressants and usual 
care by the PCP. The IPT consisted of manual-based acute phase and continuation therapy 
over eight months. At the end of treatment, significantly more patients in both the IPT and AD 
arms of the trial had recovered, compared to those receiving UC. IPT was equally effective 
as AD at any time point in these 8 months. However, compliance with IPT was low, with only 
42 % of the patients actually following the full IPT protocol.  
 
CT and CBT aim at modifying negative thoughts and beliefs and thereby also change 
behavior that might be dysfunctional and contributing to (maintenance of) depression. CBT is 
intended to be time-limited, relatively brief, active, directive, focused on current problems and 
dysfunctional thinking (Hammen 1997). Key ingredients are ‘thought-catching’ (identify 
automatic negative thoughts and challenge these) and behavioral activation.  
Among the included studies is the trial of Ward and colleagues that found similar 1-
year outcomes for CBT, NDC and UC. The study by Scott and colleagues (1997) examined 
whether brief CT had excess benefits over UC. On the short-term this proved to be the case, 
and there was also a trend towards lower subsequent relapse rates over the next year. 
However, findings from this study should be treated cautiously since it suffered from small 




  In the USA , Katon and co-workers  (1996) developed a structured program in which 
PCPs cooperated with psychologists who provided brief CBT. Additional components of this 
collaborative care approach were patient education (including a video and book) and 
monitoring of AD adherence ; patients were only included if they were willing to use AD. Of 
the total sample, 43% met criteria for a baseline MD diagnosis. Main findings of a follow-up 
after 7 months show that for these patients the CBT/co-management intervention resulted in 
greater symptom improvement than UC. No information is available on recovery or on the 
proportion of patients still meeting MD criteria at this point.  
 
Long-term effects of collaborative care with CBT or CLP (combined cohorts)  
Additional information on long-term outcome of patients with MD who participated in the 
Katon et al trials evaluating effectiveness of co-management by either a psychologist or a 
psychiatrist , is provided in two papers by Lin and others. In the first (Lin et al. 1998) , relapse 
rates are presented for patients that did not satisfy DSM criteria for MD at 7 months (n=251). 
Relapse was defined as satisfying DSM-criteria at the 19-months assessment or reporting an 
interval episode in the interval between 7 and 19 months. 37% of all patients in this combined 
cohort had experienced a relapse and this proportion was similar in the collaborative and 
usual care patients. Also, relapse rates did not differ between patients from the original CBT 
or CLP treatments. Retrospectively, patients who relapsed had had significantly more 
persistence of depressive symptoms at 7 months.  In the second paper (Lin et al. 1999) the 
focus is on outcomes for a sample consisting of patients that had a diagnosis of MD at study 
entry (n = 116). Findings show that there were no differences in depressive symptomatology 
at 19 months FU between the patients who had received the enhanced treatment (i.e.: with 
CBT or CLP) and those that had received usual care. Since short-term outcomes had been 







While enhanced treatment and collaborative care often resulted in improved short-term  
outcomes, this did not seem to prevent major depression from becoming a persistent 
disorder – whether by lack of remission, or by relapse or recurrence following initial recovery. 
None of the studies provide solid evidence for improved long-term effectiveness over usual 
care.  
Two of the included studies incorporated patient preference arms in the design, to 
allow potential participants with a strong treatment preference to be allocated to their 
treatment of choice. This was done in an attempt to overcome difficulties in recruitment and 
selective treatment drop-out, problems often encountered in the implementation of 
randomized treatment trials (Fairhurst & Dowrick 1996; Hunt et al. 2001 ). Results showed 
that in neither of these studies choice of treatment conferred additional benefit on outcome.  
 
3. 3 Organizational quality improvement  
The need for better coordinated care and for more systematic, active patient follow up to 
monitor progress over time, can be identified as central themes in recent approaches to 
improve long-term depression outcomes (Badamgarav et al. 2003; Gensichen et al. 2006). In 
recognition of the potentially recurrent or persistent nature of MD, principles of chronic illness 
management (Tiemens 1999; Andrews 2001; VonKorff et al. 2002) have become more 
integrated in acute phase treatment. Strategies have been developed and evaluated which 
not only address the contents of depression treatment, but also the context and organization 
in which this treatment is delivered. Several potentially more effective ways of delivering 
depression care within the primary care setting have been examined. Six studies, all from the 




Table 2 : Quality Improvement of Depression care  
 
 








Duration, number  
 





Outcome measures & criteria 
 





1 : NTC ; n = 117 
 
2: NTC + peer support ; n = 62 
 
3: UC;  n = 123 
NTC: 16 weeks 
mean number of  calls per 
patient: 10 
 
Peer support: (at least)  6 
months; 68% had at least 1 
contact with volunteer 
Referral by PCP or nurse 
practioner 
 
PCP diagnosis of MD or 
dysthymia 
 
Willing to start AD treatment  
 
 
N = 302 




Improvement :  
50% improvement on mean HRSD and / or 
BDI    
 






1: FB ;   n = 221 
 
2: FCM; n = 196 
 
3: UC;  n = 196 
 
16 weeks 
1:  reports after 8 and 16 wks ;  
2: as 1) + 3  telephone calls (at 
inclusion and after 8 + 16 wks);  
93% completed   
Selected from pharmacy 
records by researchers  
 
Diagnosed with depression and 
starting new AD treatment (i.e.  
no AD in previous 120 days)  
 
N = 613 




MD: SCID –Depression module  
 
Improvement: ≥ 50% in SCL-20 
 







1: FCM ; n = 207 
 
2: FCM + telephone brief CBT; n = 198 
 
3: UC;  n=195 
 
20 weeks 
FCM: 3 calls + personalised 
mailed feedback ; 85%  
completed all 3 calls 
 
FCM+CBT: 84 % completed ≥ 4 
CBT sessions 
Selected from pharmacy 
records and visit registration;  
 
Current depressive sx of 
moderate severity , 2-4 wks 
after starting new AD treatment   
 
N = 600 
75% female, mean age: 44 
 
 
SCL depression scale 
 
Patient rated global improvement 
 
at least 50% improvement in SCL-
depression score 
 
rating of (very) much improved  
 
 






1:  CM;  n = 224 
 
2:  UC;  n  = 181 
6 months   
monthly and as needed 
telephone support calls from 
caremanagers 
64%  ≥ 1 FU call in first 3 m; 
59%  ≥ 1 FU call between 4-6m 
 
 
MD and/or dysthymia 
 
Starting or changing depression 
treatment   
 
 
N =  405 
80 % ♀;  mean age: 42 
 
MD: 79 %  
MD & Dysthymia: 20 % 
 
Diagnosis: DSM-IV   
Severity of symptoms : HSCL-20   
 
Response to treatment: ≥50 decrease in 
HSCL-score;  













Duration, number  
 















1: QEC ; n = 239 
 




93 % at least 1 session with 
nurse;  
mean number of contacts in the 





MD   
 
 
N =  479 
84%  female, mean age: 43  
 
 
New treatment : n =189 ; 










Care   
 
Wells et al  








1: QI-M;  n =  424 
 
2: QI-T ;  n =  489     
 
3: UC ;   n  =  443 
 
 
12 months  
 
QI- M: 6 - 12 months 
 
QI-T: 12-16 sessions of CBT; 
most used open group CBT  
 
brief CBT (4 sessions) offered 
















N = 1356 
71 % ♀;  mean age: 44 
 
MD:  41 % 
MD & Dysthymia: 11 % 
Screen : CIDI stem questions (  ≥ 2 wks of 
depressed mood or loss of interest during 
last year or persistent depression over the 
year plus at least 1 week in past month)   
 
Diagnosis:  
CIDI  ( baseline &  24 m FU)   
 
probable MD (other FU’s ) :  
modified screener i.e.: referring to prior 6 
months and without dysthymia item ;  
 
Depressive symptoms : CES-D  
 




Table 2 :  Quality improvement continued, part B 
Authors  
 
F-U last assessment 
+ attrition 
 
RESULTS:  Depression outcome  Conclusions                                                                           
 









≥ 50% improvement  
            HRSD:           BDI:  
NTC * :  57 %            48  %   
UC :       38 %            37 %      
* Both NTC interventions combined in main analyses  
 
NTC superior to UC in symptom reduction measured by HRSD but of marginal benefit in 
BDI-scores;  
 
No additional effects of peer support to NTC  
 





6 months,  
 
94%  ( n = 575) 
 
≥ 50% improvement in SCL: 
FB:    43  % ; CM:   55  %;  UC: 40  % 
 
Probability of persistent MD at 6 m :  
FB:    15 % ;  FCM:   8 % ; UC: 15 %  
 
FCM more effective than FB only and than UC :  
- more improvement in depressive sx 
- lower probability of persistent MD 6 months after start of AD treatment 
 
FB only:  no more effective than CAU  
 
Simon et al,    
2004 
 
6 months,  
 
89%  ( n= 532) 
 
≥ 50% improvement in SCL: 
FCM: 51 %; FCM+CBT: 58 % ; UC: 43 % 
 
Patient rated improvement:  
FCM: 66 %; FCM+CBT: 80 % ; UC: 55 % 
 
 
FCM with brief CBT more effective than FCM  on itself  
 
FCM with brief CBT more effective than UC   
 
FCM and UC equally effective   
 
 




6 months  
 
80% ( n= 325) 
 
Response to treatment: CM: 60 % , UC: 47 %  
 
Remission:  CM: 37 % , UC: 27 %  
 






F-U last assessment 
+ attrition 
 
RESULTS:  Depression outcome  Conclusions                                                                           




6 months  
 
90%  ( n= 432) 
 
   
Mean reduction in CES-D scores :  
QEC: from 56 -> 37.9 =18.1 ; UC: from 55 -> 42.8 = 12.2  
 
Decrease in CES-D in patients with new treatment episode : 
QEC : 21.7 vs. UC: 13.5  
 
Decrease in CES-D in recently treated patients: 
QEC: 14.5 vs. UC: 11   
 
 
More improvement in depressive symptoms in QEC patients 
 








57 months  
 
73% ( n =  991 ) 
 
6 m FU probable disorder  : QI : 40 % , UC 50 %   
 
12 m FU probable disorder  : QI : 42 % , UC 52 %   
 
24 m FU current  MD :  
QI-M: 39 % ;  QI-T :  31 % , UC:  34 %  
 
57m FU , probable disorder:  
QI-M: 38 % ;  QI-T :  36 % , UC:  44 %  
 
6 and 12 m FU :  both QI approaches similarly improved clinical outcomes relative to UC 
 
24 m FU:  
-  more sustained benefit of QI-T    
-  no differences between rates of MD among QI-M and UC  
 
57 m FU:  
- QI-T significantly lowered rate of probable disorder relative to UC  






Practice support by nurses or care managers  
Nurses played a central role in an intervention program called Nurse Telehealth Care (NTC), 
that was evaluated by Hunkeler and associates (2000) in the USA. In this intervention, 
nurses supported patients in adhering to their AD treatment and informed PCPs about the 
progress these patients made. Key element were regular telephone calls with the patients, 
scheduled in advance. There were two versions of NTC, with one also offering additional 
peer support by trained volunteers. No additional effects for peer support were found and 
both NTC versions were combined for the outcome analyses. At six-month follow-up NTC 
patients showed greater improvement in depressive symptoms than those randomized to 
UC. No data is provided on recovery or persistence of MD.  
 Simon and collegues (2000) found that a feedback and care management (FCM) 
program that included (written) feedback of computerized data on treatment, practice support 
by a care manager, and regular monitoring and follow-up of patients by telephone, of which 
PCPs received detailed reports, significantly improved six month patient outcomes over usual 
care. This approach was found to be more effective than (written) feedback to PCPs of 
computerized data from pharmacy and visits, which included algorithm based 
recommendations for treatment, on itself ; the latter did not yield any benefits at all over usual 
care. Probability of persistent major depression at 6 months follow-up was 15%  for FCM 
patients, compared with 8% in both routine care and the feedback only group.  
 More recently, the same research group reported results of another RCT (Simon et al. 
2004) in which effectiveness of a similar, updated version of the FCM intervention was 
compared with a version that included brief structured CBT, delivered by telephone. Six 
months FU findings showed that patients assigned to the care management plus CBT 
condition were significantly more likely to experience substantial improvement in depressive 
symptoms and greater self reported improvement than patients in both other conditions (FCM 
and usual care). However, in contrast to findings of the first study, no additional beneficial 




 Dietrich et al (2004) report 6-month outcomes of a large RCT with randomization 
taking place at practice level. The intervention practices implemented a systematic approach 
to the assessment and management of depression (including dysthymia). Key elements 
included telephone follow-up of patients by a care manager (with background in primary care 
or mental health nursing) , support of this care manager and the PCP by a psychiatrist and 
increased attention to patient education and goal setting by the PCP. Brief training was 
provided to all involved parties; PCPs in the control practices were offered a 1 hour-course. 
Six months after inclusion, more patients in the care management practices were in 
remission (37% versus 27% of patients in UC practices). Interestingly , hardly any differences 
were found in the actual treatment patients had received during this period : of all patients 
about 80% had used an AD and around 25% were provided with some form of (unspecified) 
counselling. This suggests that the improved outcome could be contributed to the specific 
FU-monitoring elements of the intervention.   
 
Comprehensive practice-level  quality improvement strategies 
Two studies in the United States developed and used elaborate practice-level strategies to 
improve detection and depression management.  
In the “Quality Enhancement by Strategic Teaming” (‘Quest’) intervention (Rost et al. 
2000; 2001 a+b) the roles of all members of community primary care practice teams in the 
care process were redefined. Administrative staff was trained to screen and recruit patients 
meeting criteria for MD. Nurses were trained to be able to provide clinical services, like 
assessing depressive symptoms, providing education, stimulating adherence to treatment 
and monitor progress over time. PCPs received a brief training in which they were 
encouraged to select the type of guideline concordant treatment (pharmacotherapy and/or 
psychotherapy) the patient preferred. Effects of this intervention were studied in a RCT with 
randomization taking place at the practice level. Twelve practices participated ; in each 
intervention practice two PCP’s, one nurse and one administrative staff member were 




symptoms than patients treated in UC settings. However, this improvement was only found in 
the subgroup of patients that had started with a new treatment i.e. no AD in the past month or 
any specialty visits in the past six months). Moreover, the intervention did not have any effect 
on the outcome in patients with persistent symptoms, of whom almost 73% had used AD in 
the month before study inclusion. These patients (estimated by the authors to constitute 
approximately 56% of the sample) remained depressed: depressive symptoms in these 
patients declined less than 20%, even though the majority of them (82%) seemed to receive 
appropriate, guideline-concordant care.   
  
The Partners in Care study (Wells et al. 2000, 2004; Sherbourne et al 2001) is , as far as we 
are presently aware, the first quality improvement (QI) program at practice level to report on 
five year impact of the QI intervention relative to usual care. In the literature this study is 
described as a combination of expert intervention, local managed care organization 
involvement (mainly with organizing resources and finances) and provider behavior change 
strategies. Training of local staff of primary care clinics was used as a means to increase the 
percentage of depressed patients who would receive appropriate care. Partners in Care 
(PIC) offered a 2-day basic depression management training package to primary care 
providers, nurses and therapists. Moreover, PIC provided enhanced resources for either AD 
treatment, with access to a nurse care manager for six to twelve months of follow-up 
medication adherence support (QI-M) or to (individual or group) CBT by a study-trained 
therapist (QI-T). Control practices received copies of the guidelines, but no extra training or 
resources. All participating practices continued to have access to commonly available 
(primary care or specialist) mental health treatments. PCPs and patients were free to choose 
among treatments or to choose no treatment. The effects of both strategies were compared 
with those of usual care in a RCT, with randomization taking place at the practice level. 
Forty-two percent of the included patients had a baseline MD diagnosis, another 11% 
suffered from MD and dysthymia. After one year, both QI interventions had reduced 




(still) suffered from MD and/ or dysthymia. At the 2-year FU the therapy version of QI (i.e.: 
CBT) was found to have more sustained benefits than both other conditions when comparing 
rates of current MD (see table 2) . At the last reported FU five years after the study started , 
QI-T patients again had the lowest rates for probable depressive disorder.   
 However, interpretation of these results is complicated. By design, this study did not 
randomly assign patients to specific treatments but rather randomized opportunities for 
receiving appropriate care (Roth & Fonagy 2004). Actual treatment that patients received 
may not have been that different across conditions. In fact, all QI patients had access to CBT 
and service use data show that next to about 40% of QI-T patients, 30% of QI-M patients 
actually received at least 4 (group) CBT sessions in the first year, which was the period of 
active depression treatment. The researchers themselves state that there is no clear answer 
to the question why there were more long-term benefits of QI-T, compared with QI-M and 
usual care (Wells et al. 2004, p. 384) .     
 
Conclusion  
The QI strategies reviewed in this section primarily involve implementation of evidence based 
care on the level of primary care practices. They mostly include education for PCPs and 
other staff, and additionally provide either direct patient support or offer improved access to 
(AD or CBT) treatment. Findings show that the aid of these supportive services, and possibly 
also the involvement of other mental health specialists, may result in more favorable 
depression outcomes. However, of the six included studies only one provides outcome data 
beyond six months and only three present outcome findings in terms of remission or 
recovery; not one study reports on relapse or recurrence. Thus, at present there is only 
limited evidence for long-term effectiveness. Furthermore, interpretation of the findings is 
complicated by the great diversity and exact contents of the actual treatment that patients 
received.  
 Two studies deserve special attention. First, the study of Dietrich and coworkers, 




the intervention, given that this was probably the only element which was truly different 
between treatments. Second, the PIC study , which is unique for it’s long follow-up and is 
very informative in demonstrating the course of MD over 5 years.   
 
3. 4  Interventions aimed at reduction of relapse, recurrence and persistence 
 of depression  
In evaluating depression outcomes, the central question to be answered should be which 
treatment not only alleviates the current episode but also protects best against relapse and 
recurrence. Sustained recovery should be an important goal of depression treatment, 
irrespective of the care setting in which the patient is seen (Keller 2003) . Therefore, 
indicated or selective preventive interventions, specifically targeted at those considered to be 
at high risk,  may be necessary. Risk-reduction strategies usually focus on factors directly 
associated with the disorder (such as residual depressive symptoms) or at enhancing 
protective aspects or circumstances, including self-management and coping. We found four 
studies, three from the USA , testing this approach in primary care. These will be presented 
in more detail in this paragraph. The studies are summarized in table 3.  
 Katon and coworkers (1999, 2002) evaluated an intervention targeted at patients with 
persistent symptoms of depression, despite their being treated with antidepressants for 6 to 8 
weeks (stepped collaborative care). Patients in the intervention group received psycho-
education and increased frequency of visits by a psychiatrist collaborating with the PCP (CLP 
as described in 3.2) . After six months, 44 % of I-patients and 31% of UC controls had 
recovered. However, only patients with moderate symptom severity at study entry (65 % of 
the sample; Walker et al 2000) were found to benefit from this shared care, while there were 
no effects for patients initially suffering from more severe symptoms. Sustained improvement 
during the next 2 years was found only in the CLP-patients with depression of moderate 




Table 3: Primary care interventions aimed at reducing risk of relapse, recurrence, chronicity 
 










Patient sample  Outcome measures &  
criteria  
 






1: CLP : 2-4 visits with liaison 
psychiatrist; pharmacotherapy; 
monitoring of follow-up visits and AD-
adherence; patient education;  n =  114  
 
2: UC;  n = 114 
 
2 – 4 mths  of shared 
care and as-needed 
consultation available 
for PCP  
 
mean number of 
patient visits : 2.75 
 




pharmacy and visit 
data  
 
Persistent symptoms  
after 6-8 weeks of AD;   
 
≥  4 DSM-IV MD 
symptoms +  SCL-20   
mean score ≥ 1   
 
 
n = 228 
  
74 % ♀ , mean age 47  
 
recurrent MD: 80%;  






Severe depression: SCL > 2  
Moderate depression : SCL ≤ 2 
 
Recovery :  0 -1 DSM-IV MD sx  
 
 





1: Relapse Prevention Program (RPP) 
by depression specialist: n = 194 
 
2: UC;  n = 192 
 
1 year 








Recovered but at  high 
risk for relapse after 6-
8 weeks of AD:  
< 4 DSM –IV MD sx +  
≥ 3 prior episodes of 
MD or dysthymia; OR 
4 residual sx,  SCL-20 
mean score  < 1 and 
history of MD or 
dysthymia 
 
N = 368 
 
74% ♀, mean age: 46  
 
recurrent MD: 75%;  








SCL- 20  
Relapse/recurrence: meeting criteria for MD  
 
Recovery: Not meeting criteria MD 
 




1: DRP; n = 112 
 
2: PC+DRP; n = 39 
 
3: CBT +DRP; n = 44 
 
4: UC; n = 72  
 
 
Max. 36 months; 
92% of all 3 DRP 
patients attended 3 
sessions with 
prevention specialist; 
94% at least one   
 
3 stage procedure: 






Current MD  
(ipresent in last 2-12 
weeks)  
 
N = 267 






Diagnosis : CIDI  
 
















Patient sample  Outcome measures &  
criteria  
 







1: Enhanced care with continuation 
phase (EC);  n = 115  
 
2: UC ; n = 96 
 
6 months plus max. 2 
year continuation  
94 %  at least 1 
contact during initial 
6-m EC; mean 
number of contacts: 
5; 83 % at least 1 
contact during  
continuation phase;   





DSM-IV MD  
  
new treatment episode  
at study entry  
 
persitent symptoms 
after 6 months of 
treatment 
 
N = 211 
84%  female 
Mean age: 43  
 
(EC patients sign 
younger: 40 vs. 47) 
  
73% recurrent MD;  
 




Modified CES-Depression scale  
 












Last F-U   
& attrition 
 









28 months,   
 
75 % (n = 171)  
 
 
Recovery after 6 months : CC: 44 % vs. UC: 31 % 
 
Depression severity ( mean SCL-20 score) at 28 m:   
Overall: I: 1.16, C: 1.19 
moderate severity : 1.23 vs 0.88   
high severity:          1.16 vs 1.19 
 
At 6 months:  
-  significantly more intervention patients recovered ; I-patients recovered faster 
 
At 28-months:  
- continued improvement in I-patients in the moderate severity group     
- no outcome differences in the high severity group 
 
 







85% ( n = )  
(RPP 90% , UC 79%) 
 
Relapse / recurrence rates: RPP: 35 % vs. UC:  35 %  
 
Depressive symptoms: SCL-20 scores of RPP-patients on 
average 0.08 points below those of UC patients  
 
-  no differences in overall rates of relapse / recurrence of MD over 1 year 
 









85% ( n = 226)   
 
Recovered : overall 67%  
DRP: 61%, PC+DRP: 79%; CBT+DRP: 70% ; UC: 68%  
 
Depressed full 27 weeks:  
DRP: 20%, PC+DRP: 6%; CBT+DRP: 15 % ; UC: 17%  
   
 
DRP did not result in better 6-month outcomes over UC  
 
No evidence for added beneficial effects of additional CBT and PC over DRP only 
  
 
Rost et al , 
2002 
 
24 months  
 
67% ( n = 142)    
 
 
Remission over 2 years:  











In a related trial (Katon et al. 2001), an intervention targeted at patients who were recovered 
but considered to be at high risk for relapse because of their depression history (recurrent 
episodes or dysthymia) was studied. This Relapse Prevention Program (RPP) focused on the 
continued use of antidepressants, the timely recognition of relapse/recurrence through 
systematic monitoring of symptoms and the development of a personal relapse prevention 
plan (Ludman et al. 2000). Patients in the intervention group were offered two primary care 
visits with a depression specialist (a psychologist, social worker or nurse practioner), followed 
by three telephone contacts over a one-year period. Twelve month FU assessments showed 
that , although RPP-patients experienced less depressive symptoms across FU, they did not 
experience fewer episodes of depression. Overall relapse rates over 1 year were similar 
(35%), showing that the RPP did not improve outcome over usual care. 
 The RPP study of Katon and coworkers was replicated with a modified version of the 
intervention in the Netherlands by Smit and colleagues (Smit et al. 2006, 2005). In this trial , 
aimed at ‘new’ as well as chronic MD patients, effectiveness of enhanced care with a 
continuation-phase was evaluated. Primary intervention was the Depression Recurrence 
Prevention (DRP) Program ( Tiemens et al. 1998) that focused on improving patients’ 
resilience and self-management skills and was based on an ongoing relationship between 
patient, prevention specialist and PCP. Six-month follow up findings showed that 67% of all 
patients had recovered, while 17% remained depressed.  Enhanced care did not result in 
improved outcomes over usual care. Furthermore, there were no indications for any surplus 
effects of addition of a psychiatric consultation or CBT to the basic format of the DRP. 
Presently, a publication on 3-year effects is underway (Conradi et al., in preparation).  
 Finally, Rost et al (2002) evaluated effects of a chronic illness approach to depression 
management. Key element was continued care management by practice nurses, which was 
targeted more specifically at patients still reporting high numbers of depressive symptoms 
after being treated for 6 months. All patients had had a new episode of MD at study inclusion. 
The ongoing intervention was matched to the persistence of depression, with patients 




and antidepressant use and providing feedback to the PCPs. Patients whose symptoms 
persisted were encouraged to visit their PCP. By 24 months, 74% of enhanced and 41% of 
usual care patients met criteria for remission, so that the continuation of care management 
resulted in significantly higher remission rates.    
 
Conclusion  
Further targeting of treatment to individual patients considered to be at risk seems a rational 
way to improve long-term patient outcomes. Results of the 4 studies that incorporated 
recurrence and chronicity prevention strategies to test this hypothesis in primary care 
populations varied. The only study to report 1-year relapse rates found no evidence for 
additional protective effects of RPP over usual care. Only one study did clearly demonstrate 
superiority of this approach.  
 
3.5 Relapse / recurrence prevention in other care settings  
Since there is a lack of studies performed in primary care, we looked elsewhere for 
information on potentially more effective relapse/recurrence prevention strategies to improve 
long-term depression outcome. We performed a new search of the depression literature , 
now focusing on research conducted in non-primary care settings (outpatient care, 
community settings) with treatment targeted specifically at high-risk factors. The main 
findings of this additional search will be described briefly in this section.   
 In the outpatient setting, issues concerning the long-term outcome of MD and 
consequences for it’s treatment have already been evident longer. Several longitudinal 
studies had shown depression as a disorder characterized by high risks of relapse and 
recurrence, despite treatment ( Keller 1994; Mueller et al. 1999). Much research in this 
setting focused on the potentially protective effects of continued AD use in those considered 
to be at high risk, which is now generally defined as three or more previous episodes (see 




et al. 1998; Geddes et al. 2003) although still not much information is available on necessary 
length of AD treatment, and compliance remains an issue.  
 In comparison, psychological interventions specifically aimed at improving long-term 
outcome were only developed and evaluated fairly recently.  Although IPT was the first 
psychotherapy to be examined for its benefits as a maintenance therapy in outpatients 
(Frank et al. 1990;1991), the field seems to be dominated by studies investigating the 
effectiveness of various versions of CBT , either targeted at persistent or residual symptoms 
after treatment with AD (Fava et al. 1996, 1998a , Paykel et al. 1999; Scott et al. 2000) or at 
patients with recurrent depression (Fava et al. 1998b, 2004; Jarrett et al. 2001). Also, new 
therapies have been developed that often integrate elements of other therapies , such as the 
cognitive behavioral-analysis system of psychotherapy (CBASP; McCullough, 2000) and 
mindfulness-based cognitive therapy (MBCT; Segal et al. 2002).  
 Promising findings from these studies add to the evidence that this targeted strategy 
is effective with outpatients. For example, Paykel and Scott found lower relapse rates in 
outpatients who had previously recovered with AD but continued to suffer from residual 
symptoms, for which they then received CBT (n = 80). Over a period of 17 months , fewer 
CBT than UC patients suffered a relapse (23 % of CBT and 35 % of usual care patients 
respectively). Recently, results of an extended follow-up of this patient sample were 
published (Paykel et al.  2005). Findings indicated that CBT delayed recurrences, that were 
spread more evenly for CBT than for UC patients over a 6 year-period. Nevertheless, 
although protective effects of CBT had seemed to persist for some time, no significant 
differences in total recurrence rates were present and 60 to 65% of all patients had 
experienced at least one recurrence in this period.   
 In the study by Jarrett and associates (2001) the hypothesis that continuation-phase 
cognitive therapy (C-CT) would reduce relapse rates more than acute phase CT only in  
outpatients with a history of recurrent MD tested. Patients who had responded to acute CT (n 
= 84) were subsequently randomized to either 8 months of C-CT (10 additional sessions ) or 




maintaining skills to prevent relapse / recurrence and the (further) development of coping 
strategies to face identified personal vulnerabilities. After these 8 months, 10% of C-CT 
patients versus 31% of the controls had experienced a relapse, demonstrating that the 
addition of specific continuation CT was more effective.  
 CBASP was developed specifically for the treatment of chronic and recurrent MD. 
This manualized therapy combines elements from behavioral, cognitive, psychodynamic and 
interpersonal techniques to achieve more effective coping and improvement of interpersonal 
social skills (Keller et al. 2000). In the literature CBASP is described as being more 
structured and directive than IPT and as different from CBT by focusing primarily on 
interpersonal interactions. Klein and associates (2004) report on 1 year effects of CBASP in 
remitted outpatients (n = 82) who were assigned to monthly maintenance CBASP-sessions 
or to assessment only, without any formal treatment. Recurrence rates were significantly 
lower in the CBASP-patients (11% versus 32% in the other participants), demonstrating that 
sustained remission can be achieved through low-intensive continuation of the therapy to 
which patients had responded in an earlier stage.  
 
Effectiveness of relapse and recurrence prevention strategies have in recent years also been 
studied in convenience samples . Again, CBT in most cases is the treatment of choice.  Ma 
and Teasdale (2004) conducted a RCT to examine 1-year protective effects of a novel form 
of group therapy, MBCT. This is described as a manualized skills-training program, based on 
an integration of aspects of traditional  CBT for MD and components of a stress reduction 
program (Teasdale et al. 2000).  Effects were evaluated in a sample (n=75)  of individuals 
with a history of recurrent MD who were recruited from primary care practices and through 
media advertisements.  Over a period of 14 months, 39% of the MBCT patients versus 62% 
of the control patients experienced a relapse or recurrence (these are not presented 
separately). Protective effects of MBCT were strongest in those with at least 3 previous 
episodes , constituting roughly 75% of the sample. Although promising, the benefit of MBCT 




include no treatment at all. Service use data show that about 65 % of control patients had no 
depression-related visits with their GP during the study period, fewer than 30% received a 
form of professional mental health support and around 35% used AD for at least part of the 
time.  
 Finally, a recent study in the Netherlands by Bockting and coworkers (2005) also 
focused on protective effects of group CT in individuals with recurrent MD, who were in 
remission at study entry. Patients included in this RCT were recruited through media 
announcements (69%) and at outpatient psychiatric centers (31%). Patients were 
randomized to either group CT or assessment only and followed up for 2 years. Main findings 
show that group CT was effective in reducing relapse/recurrence, but only in patients with 
five or more previous episodes (41% of the total sample). Of special interest is that this 
difference in relapse/recurrence rates was achieved in the first 3 months and remained stable 
over FU. No significant differences were found in AD use and psychological treatment, either 
in treatment of the last episode before study entry (when about 60% received a combination 
of psychotherapy/counselling with AD ) or during the 2 year study period (41 % treated with 
combination of ‘pills and talk’). Thus, effect of 8 weeks of group CT seemed not to be 
moderated by various other treatments.     
  
Conclusion  
Risk factors for unfavorable long-term outcome that are the target for specific continuation- or 
maintenance-therapy , are mainly incomplete recovery (residual symptoms) and recurrent 
major depression, with growing evidence that the number of previous episodes is also of 
relevance.  Study findings demonstrate the growing evidence base for effectiveness of this 
targeted approach in reducing relapse /recurrence rates over time.  The mechanism behind 
this success is probably that patients learn to integrate certain protective skills in their daily 
life and behavior, while the additional provision of regular monitoring contacts acts as a kind 
of booster. Nevertheless, these findings also underscore the persistent nature of MD since in 




4 General conclusions 
Given that major depression often follows a chronic course, with few people having only one 
isolated episode and primary care in many cases being the main treatment setting, the core 
question we wanted to answer with this systematic literature search  was: what is an effective 
method to improve long-term outcome for depression in primary care?  Summing up the 
results of the reviewed studies, we can conclude that :  
1: Training of PCPs, which has long been thought of as the major vehicle for improving 
depression outcomes, has not fulfilled its promise. On its own, this appears ineffective in 
achieving better long-term outcome.  
2: Supporting PCPs by enhanced treatment and collaborative care may result in improved 
short-term outcomes, but does not seem to prevent recurrence. No solid evidence is 
available that supports claims of increased effectiveness over usual care. Thus, beneficial 
effects of adding psychiatric consultation , counselling or psychotherapy (CBT, IPT) to usual 
care do not appear to persist over time.  
3: Quality improvement strategies, adressing both the contents of treatment as well as the 
broader care context in which treatment is delivered , show improved outcomes at 6 months 
though at present there is still limited evidence for it’s effectiveness over usual care. There is 
some evidence of longer term effectiveness. Interpretation of QI-findings is complicated by 
the great diversity and exact contents of the treatment that patients across conditions actually 
received. 
4: It as as yet inconclusive whether the approach in which tailored interventions aimed at 
prevention of relapse, recurrence and chronicity or targeted at specific high-risk patients 
succeed in improving long-term course and outcome of depression.  
5: Studies involving targeted approaches in outpatient or convenience samples, show that 
psychotherapy (especially -individual or group- CBT) can have protective effects on the 
longer run. These findings challenge the assumption of continued use of antidepressants as 






Improving the detection and accuracy of diagnosing and treating depressive disorders in 
primary care has always received much attention. However, the idea that improved 
recognition would automatically result in more adequate treatment and hence, a better 
prognosis, has proven to be too optimistic. Active and sustained follow-up of patients to 
monitor depression course and outcome, including persistence of residual symptoms and 
early signs of relapse/recurrence, and to support patients’ self-care skills where possible, 
may be required. Assigning such care management tasks to nurses or (other) professionals 
cooperating with PCPs is mostly well-received and feasible, but as main findings of this 
review show, effectiveness on the longer run is as yet undecided. Although certainly progess 
has been made, most studies have not demonstrated succes in the prevention of recurrence 
and chronicity of major depresion and moreover, with some exceptions, no excess benefit 
over usual care was demonstrated; the exceptions concern US-based studies , which might 
point at differences in the nature and quality of usual care between the US and Europe. 
Unfortunately, we did not find a clear answer to our question. We conclude that for improving 
the long-term outcome of major depression in primary care new directions are needed to 
resolve the problems.  
 
 
  
 
160 
